Cardiovascular risks in smokers treated with nicotine replacement therapy: a historical cohort study

Jens Dollerup1 Dollerup Medical Consultancy, Kongens Lyngby, Denmark

Jørgen Vestbo2 Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, University of Manchester, Manchester, UK

Tarita Murray-Thomas3 Clinical Practice Research Datalink, Medicines and Healthcare products Regulatory Agency, London, UK

Alan Kaplan4 Family Physician Airways Group of Canada, Richmond Hill, ON, Canada

Richard J Martin5 National Jewish Health, Denver, CO, USA

Emilio Pizzichini6 Federal University of Santa Catarina, Santa Catarina, Brazil

Marcia M M Pizzichini6 Federal University of Santa Catarina, Santa Catarina, Brazil

Anne Burden7 Observational and Pragmatic Research Institute Pte Ltd, Singapore

Jessica Martin7 Observational and Pragmatic Research Institute Pte Ltd, Singapore

David B Price7 Observational and Pragmatic Research Institute Pte Ltd, Singapore;8 Centre for Academic Primary Care, University of Aberdeen, Aberdeen, UKCorrespondence[email protected]

show all

Cardiovascular risks in smokers treated with nicotine replacement therapy: a historical cohort study

Articles from other publishers (13)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Cardiovascular risks in smokers treated with nicotine replacement therapy: a historical cohort study

Citations (13)

Articles from other publishers (13)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date